« That's Where The Money Is |
| Sulfolane »
November 16, 2012
Part Eleven? Really?
And here's another item, sent in by a reader, who noted this publication in Bioorganic and Medicinal Chemistry Letters. I have no problem with the work at all, and certainly no problem with the people who did it (some of whom I know), but Part Eleven? I'm trying to figure out why this would be sliced quite so thinly - the only thing that comes to mind is to scatter a wide group of co-authors across several publications, so as to give everyone something on their CV. But how much does a multipart BOMCL count for - heck, while we're on the subject, how much does most any publication count for in today's hiring environment? Update: note that this is not one of those multiyear series things - most of these appear to be in press right now.
+ TrackBacks (0) | Category: The Scientific Literature
POST A COMMENT
- RELATED ENTRIES
- AstraZeneca's Move To Hot, Happening Cambridge
- Stealing A Compound, To Set Up in China
- Tecfidera's Price
- Novartis Loses the Glivec Patent Fight in India
- ChemBark Closing Down (Update: Not Really!)
- Fake Journals - But They'd Like Real Money
- Chemical Probes Versus Drugs
- Two New Books